Drug Shortage Report for LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION USP
Report ID | 1479 |
Drug Identification Number | 02439468 |
Brand name | LIDOCAINE HYDROCHLORIDE 2% AND EPINEPHRINE 1:200000 INJECTION USP |
Common or Proper name | Lidocaine with Epinephrine |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | LIDOCAINE HYDROCHLORIDE EPINEPHRINE |
Strength(s) | 20MG 0.005MG |
Dosage form(s) | SOLUTION |
Route of administration | BLOCK/INFILTRATION EPIDURAL |
Packaging size | 20mL x 5 |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Shortage of an inactive ingredient or component. |
Anticipated start date | |
Actual start date | 2017-02-02 |
Estimated end date | |
Actual end date | 2017-03-13 |
Shortage status | Resolved |
Updated date | 2017-06-29 |
Company comments | Duplicate entry (Report ID Reference 2503) |
Health Canada comments | |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.